These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32913568)

  • 41. The value of diffusion-weighted imaging in the diagnosis of medication-related osteonecrosis of the jaws.
    Muraoka H; Ito K; Hirahara N; Okada S; Kondo T; Kaneda T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Sep; 132(3):339-345. PubMed ID: 34092542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medication-related Osteonecrosis of the Jaw: A Review.
    AlDhalaan NA; BaQais A; Al-Omar A
    Cureus; 2020 Feb; 12(2):e6944. PubMed ID: 32190495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?
    Klingelhöffer C; Klingelhöffer M; Müller S; Ettl T; Wahlmann U
    Dentomaxillofac Radiol; 2016; 45(5):20160065. PubMed ID: 27213837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF-SIPMO and AAOMS Guidelines.
    De Cicco D; Boschetti CE; Santagata M; Colella G; Staglianò S; Gaggl A; Bottini GB; Vitagliano R; D'amato S
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Interpretation of medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline].
    Chen H; He Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Feb; 57(2):128-135. PubMed ID: 35152647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
    Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
    Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy.
    Traboulsi-Garet B; Jorba-García A; Camps-Font O; Alves FA; Figueiredo R; Valmaseda-Castellón E
    Clin Oral Investig; 2022 Mar; 26(3):2371-2382. PubMed ID: 35124731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw.
    Kitagawa Y; Ohga N; Asaka T; Sato J; Hata H; Helman J; Tsuboi K; Amizuka N; Kuge Y; Shiga T
    Jpn Dent Sci Rev; 2019 Nov; 55(1):65-70. PubMed ID: 30949253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study.
    Otto S; Schnödt EM; Haidari S; Brunner TF; Aljohani S; Mosleh M; Ristow O; Troeltzsch M; Pautke C; Ehrenfeld M; Fliefel R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):519-526. PubMed ID: 33309263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tocilizumab: Another medication related to osteonecrosis of the jaws? A case report and literature review.
    Sakkas A; Heil S; Kargus S; Rebel M; Mischkowski RA; Thiele OC
    GMS Interdiscip Plast Reconstr Surg DGPW; 2021; 10():Doc03. PubMed ID: 33928006
    [No Abstract]   [Full Text] [Related]  

  • 52. Tomographic study of Jaw bone changes in patients with bisphosphonate-related osteonecrosis.
    Simpione G; Caldas RJ; Soares MQS; Rubira-Bullen IRF; Santos PSS
    J Clin Exp Dent; 2020 Mar; 12(3):e285-e290. PubMed ID: 32190200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition.
    Migliario M; Mergoni G; Vescovi P; Martino I; Alessio M; Benzi L; Renò F; Fusco V
    Dent J (Basel); 2017 Mar; 5(1):. PubMed ID: 29563419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relevant factors for treatment outcome and time to healing in medication-related osteonecrosis of the jaws - A retrospective cohort study.
    Martins AS; Correia JA; Salvado F; Caldas C; Santos N; Capelo A; Palmela P
    J Craniomaxillofac Surg; 2017 Oct; 45(10):1736-1742. PubMed ID: 28838836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
    Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
    J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series.
    Pardo-Zamora G; Martínez Y; Moreno JA; Ortiz-Ruíz AJ
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective Percutaneous Controlled Radiofrequency Thermocoagulation of the Gasserian Ganglion To Control Facial Pain Due to Medication-Related Osteonecrosis of the Jaw.
    Taniguchi A; Fukazawa K; Hosokawa T
    J Palliat Med; 2017 Oct; 20(10):1171-1174. PubMed ID: 28772087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication-Related Osteonecrosis of the Jaw (MRONJ) due to Simvastatin: An Unusual Case Report.
    Samieirad S; Labafchi A; Famili K; Hashemzadeh H
    World J Plast Surg; 2021 Jan; 10(1):132-135. PubMed ID: 33833966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication related osteonecrosis of the jaws (MRONJ): Factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement.
    Sánchez-Gallego Albertos C; Del Castillo Pardo de Vera JL; Viejo Llorente A; Cebrián Carretero JL
    Med Oral Patol Oral Cir Bucal; 2021 Nov; 26(6):e684-690. PubMed ID: 34704981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salivary Biomarkers Associated With Bone Deterioration in Patients With Medication-Related Osteonecrosis of the Jaws.
    Kolokythas A; Karras M; Collins E; Flick W; Miloro M; Adami G
    J Oral Maxillofac Surg; 2015 Sep; 73(9):1741-7. PubMed ID: 25889372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.